Economic burden of respiratory syncytial virus infection in adults: a systematic literature review

References

• Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev. 2000;13(3):371–384.
   PubMed Web of Science ®Google Scholar
• Falsey AR, Hennessey PA, Formica MA, et al. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352(17):1749–1759.
   PubMed Web of Science ®Google Scholar
• Tin Tin Htar M, Yerramalla MS, Moïsi JC, et al. The burden of respiratory syncytial virus in adults: a systematic review and meta-analysis. Epidemiol Infect. 2020;148:e48.
   PubMed Web of Science ®Google Scholar
• Boe DM, Boule LA, Kovacs EJ. Innate immune responses in the ageing lung. Clin Exp Immunol. 2017;187(1):16–25.
   PubMed Web of Science ®Google Scholar
• Coultas JA, Smyth R, Openshaw PJ. Respiratory syncytial virus (RSV): a scourge from infancy to old age. Thorax. 2019;74(10):986–993.
   PubMed Web of Science ®Google Scholar
• Jansen AG, Sanders EA, Hoes AW, et al. Influenza- and respiratory syncytial virus-associated mortality and hospitalisations. Eur Respir J. 2007;30(6):1158–1166.
   PubMed Web of Science ®Google Scholar
• Walsh EE, Peterson DR, Falsey AR. Risk factors for severe respiratory syncytial virus infection in elderly persons. J Infect Dis. 2004;189(2):233–238.
   PubMed Web of Science ®Google Scholar
• Savic M, Penders Y, Shi T, et al. Respiratory syncytial virus disease burden in adults aged 60 years and older in high-income countries: a systematic literature review and meta-analysis. Influenza Other Respir Viruses. 2022;17(1):e13031.
   PubMed Web of Science ®Google Scholar
• Shi T, Vennard S, Jasiewicz F, et al. Disease burden estimates of respiratory syncytial virus related acute respiratory infections in adults with comorbidity: a systematic review and meta-analysis. J Infect Dis. 2022;226(Suppl 1):S17–s21.
   PubMed Web of Science ®Google Scholar
• Branche A, Granieri E, Walsh E, et al. 733. Incidence and evaluation of the change in functional status associated with respiratory syncytial virus infection in hospitalized older adults. Open Forum Infect Dis. 2018;5(suppl_1):S263–S263.
   Google Scholar
• Tseng HF, Sy LS, Ackerson B, et al. Severe morbidity and short- and mid- to long-term mortality in older adults hospitalized with respiratory syncytial virus infection. J Infect Dis. 2020;222(8):1298–1310.
   PubMed Web of Science ®Google Scholar
• Wyffels V, Kariburyo F, Gavart S, et al. A real-world analysis of patient characteristics and predictors of hospitalization among US medicare beneficiaries with respiratory syncytial virus infection. Adv Ther. 2020;37(3):1203–1217.
   PubMed Web of Science ®Google Scholar
• Descamps A, Lenzi N, Galtier F, et al. In-hospital and midterm post-discharge complications of adults hospitalised with respiratory syncytial virus infection in France, 2017-2019: an observational study. Eur Respir J. 2022;59(3):2100651.
   PubMed Web of Science ®Google Scholar
• Walsh E, Lee N, Sander I, et al. RSV-associated hospitalization in adults in the USA: a retrospective chart review investigating burden, management strategies, and outcomes. Health Sci Rep. 2022;5(3):e556.
   PubMedGoogle Scholar
• Korsten K, Adriaenssens N, Coenen S, et al. Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study. Eur Respir J. 2021;57(4):2002688.
   PubMed Web of Science ®Google Scholar
• Kumar R, Dar L, Amarchand R, et al. Incidence, risk factors, and viral etiology of community-acquired acute lower respiratory tract infection among older adults in rural North India. J Glob Health. 2021;11:04027.
   PubMed Web of Science ®Google Scholar
• Praphasiri P, Shrestha M, Patumanond J, et al. Underlying cardiopulmonary conditions as a risk factor for influenza and respiratory syncytial virus infection among community-dwelling adults aged ≥ 65 years in Thailand: findings from a two-year prospective cohort study. Influenza Other Respir Viruses. 2021;15(5):634–640.
   PubMed Web of Science ®Google Scholar
• Li Y, Kulkarni D, Begier E, et al. Adjusting for case under-ascertainment in estimating RSV hospitalisation burden of older adults in high-income countries: a systematic review and modelling study. Infect Dis Ther. 2023;12(4):1137–1149.
   PubMedGoogle Scholar
• Shi T, Denouel A, Tietjen AK, et al. Global disease burden estimates of respiratory syncytial virus-associated acute respiratory infection in older adults in 2015: a systematic review and meta-analysis. J Infect Dis. 2020;222(Suppl 7):S577–s583.
   PubMedGoogle Scholar
• Griffiths C, Drews SJ, Marchant DJ. Respiratory syncytial virus: infection, detection, and new options for prevention and treatment. Clin Microbiol Rev. 2017;30(1):277–319.
   PubMed Web of Science ®Google Scholar
• Janet S, Broad J, Snape MD. Respiratory syncytial virus seasonality and its implications on prevention strategies. Hum Vaccin Immunother. 2018;14(1):234–244.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang X, Broberg EK, et al. Seasonality of respiratory syncytial virus and its association with meteorological factors in 13 european countries, week 40 2010 to week 39 2019. Euro Surveill. 2022;27(16):2100619.
   PubMedGoogle Scholar
• Obando-Pacheco P, Justicia-Grande AJ, Rivero-Calle I, et al. Respiratory syncytial virus seasonality: a global overview. J Infect Dis. 2018;217(9):1356–1364.
   PubMed Web of Science ®Google Scholar
• Taleb SA, Al Thani AA, Al Ansari K, et al. Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches. Eur J Clin Microbiol Infect Dis. 2018;37(10):1817–1827.
   PubMed Web of Science ®Google Scholar
• Hamid S, Winn A, Parikh R, et al. Seasonality of respiratory syncytial virus - United States, 2017-2023. MMWR Morb Mortal Wkly Rep. 2023;72(14):355–361.
   PubMedGoogle Scholar
• Falsey AR, Cameron A, Branche AR, et al. Perturbations in respiratory syncytial virus activity during the SARS-CoV-2 pandemic. J Infect Dis. 2022;227(1):83–86.
   PubMed Web of Science ®Google Scholar
• Li ZJ, Yu LJ, Zhang HY, et al. Broad impacts of coronavirus disease 2019 (COVID-19) pandemic on acute respiratory infections in China: an observational study. Clin Infect Dis. 2022;75(1):e1054–e1062.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. RSV-NET interactive dashboard. 2022. https://www.cdc.gov/rsv/research/rsv-net/dashboard.html
   Google Scholar
• McLaughlin JM, Khan F, Begier E, et al. Rates of medically attended RSV among US adults: a systematic review and meta-analysis. Open Forum Infect Dis. 2022;9(7):ofac300.
   PubMed Web of Science ®Google Scholar
• Onwuchekwa C, Moreo LM, Menon S, et al. Underascertainment of respiratory syncytial virus infection in adults due to diagnostic testing limitations: a systematic literature review and meta-analysis. J Infect Dis. 2023; jiad012.
   Web of Science ®Google Scholar
• Widmer K, Zhu Y, Williams JV, et al. Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis. 2012;206(1):56–62.
   PubMed Web of Science ®Google Scholar
• Zhang S, Wahi-Singh P, Wahi-Singh B, et al. Costs of management of acute respiratory infections in older adults: a systematic review and meta-analysis. J Glob Health. 2022;12:04096.
   PubMed Web of Science ®Google Scholar
• Nguyen-Van-Tam JS, O'Leary M, Martin ET, et al. Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries. Eur Respir Rev. 2022;31(166):220105.
   PubMed Web of Science ®Google Scholar
• Youssef Y, Chmaisse A, Boutros C, et al. The burden of respiratory syncytial virus (RSV) infection in the Middle east and North africa (MENA) region across age groups: a systematic review. Vaccine. 2021;39(29):3803–3813.
   PubMed Web of Science ®Google Scholar
• Critical Appraisal Skills Programme. CASP economic evaluation checklist. 2018. https://casp-uk.net/images/checklist/documents/CASP-Economic-Evaluation-Checklist/CASP-Economic-Evaluation-Checklist-2018_fillable_form.pdf
   Google Scholar
• Drummond M, Sculpher M, Claxton K, et al. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 2015.
   Google Scholar
• Ackerson B, An J, Sy LS, et al. Cost of hospitalization associated with respiratory syncytial virus infection versus influenza infection in hospitalized older adults. J Infect Dis. 2020;222(6):962–966.
   PubMed Web of Science ®Google Scholar
• Amand C, Tong S, Kieffer A, et al. Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis. BMC Health Serv Res. 2018;18(1):294.
   PubMedGoogle Scholar
• Belk K, Clark L, Mallow P, et al. POSC190 hospital utilization for elderly patients diagnosed with respiratory syncytial virus (RSV) versus influenza in the US. Value Health. 2022;25(1):S138.
   Web of Science ®Google Scholar
• Bosco E, van Aalst R, McConeghy KW, et al. Estimated cardiorespiratory hospitalizations attributable to influenza and respiratory syncytial virus among long-term care facility residents. JAMA Netw Open. 2021;4(6):e2111806.
   PubMed Web of Science ®Google Scholar
• Chen L, Han X, Li Y, et al. Comparison of clinical characteristics and outcomes between respiratory syncytial virus and influenza-related pneumonia in China from 2013 to 2019. Eur J Clin Microbiol Infect Dis. 2021;40(8):1633–1643.
   PubMed Web of Science ®Google Scholar
• Choi Y, Hill-Ricciuti A, Branche AR, et al. Cost determinants among adults hospitalized with respiratory syncytial virus in the United States, 2017-2019. Influenza Other Respir Viruses. 2022;16(1):151–158.
   PubMedGoogle Scholar
• El Sherif M, McNeil S, Andrew M, et al. Prevalence, severe outcomes, and costs associated with respiratory syncytial virus (RSV) in adults ≥ 50 years of age hospitalized with respiratory illness in Canada, 2012-2015; abstract no. E&E-17. 6th ReSViNET conference. Virtual; 2021.
   Google Scholar
• Lonnet G, Bracke B, Molnar D, et al. POSB60 evolution of direct medical costs associated with respiratory syncytial virus disease in older adults: a retrospective database analysis from 2008 to 2017. Value Health. 2022;25(1):S71–S72.
   Web of Science ®Google Scholar
• Mao Z, Li X, Korsten K, et al. Economic burden and health-related quality of life of respiratory syncytial virus and influenza infection in european community-dwelling older adults. J Infect Dis. 2022;226(Suppl 1):S87–S94.
   PubMed Web of Science ®Google Scholar
• Mesa-Frias M, Rossi C, Emond B, et al. Incidence and economic burden of respiratory syncytial virus among adults in the United States: a retrospective analysis using 2 insurance claims databases. J Manag Care Spec Pharm. 2022;28(7):753–765.
   PubMed Web of Science ®Google Scholar
• Pastula ST, Hackett J, Coalson J, et al. Hospitalizations for respiratory syncytial virus among adults in the United States, 1997-2012. Open Forum Infect Dis. 2017;4(1):ofw270.
   PubMed Web of Science ®Google Scholar
• Prasad N, Newbern EC, Trenholme AA, et al. The health and economic burden of respiratory syncytial virus associated hospitalizations in adults. PLoS One. 2020;15(6):e0234235.
   PubMed Web of Science ®Google Scholar
• Rafferty E, Paulden M, Buchan SA, et al. Evaluating the individual healthcare costs and burden of disease associated with RSV across age groups. Pharmacoeconomics. 2022;40(6):633–645.
   PubMed Web of Science ®Google Scholar
• Yoon JG, Noh JY, Choi WS, et al. Clinical characteristics and disease burden of respiratory syncytial virus infection among hospitalized adults. Sci Rep. 2020;10(1):12106.
   PubMed Web of Science ®Google Scholar
• Atamna A, Babich T, Froimovici D, et al. Morbidity and mortality of respiratory syncytial virus infection in hospitalized adults: comparison with seasonal influenza. Int J Infect Dis. 2021;103:489–493.
   PubMed Web of Science ®Google Scholar
• Boattini M, Almeida A, Christaki E, et al. Severity of RSV infection in Southern european elderly patients during two consecutive winter seasons (2017-2018). J Med Virol. 2021;93(8):5152–5157.
   PubMed Web of Science ®Google Scholar
• Falsey AR, Walsh EE, House S, et al. Risk factors and medical resource utilization of respiratory syncytial virus, human metapneumovirus, and influenza-related hospitalizations in adults. A global study during the 2017-2019 epidemic seasons (hospitalized acute respiratory tract infection [HARTI] study). Open Forum Infect Dis. 2021;8(11):ofab491.
   PubMed Web of Science ®Google Scholar
• Goldman CR, Sieling WD, Alba LR, et al. Severe clinical outcomes among adults hospitalized with respiratory syncytial virus infections, New York city, 2017-2019. Public Health Rep. 2022;137(5):929–935.
   PubMed Web of Science ®Google Scholar
• Lee N, Chan MC, Lui GC, et al. High viral load and respiratory failure in adults hospitalized for respiratory syncytial virus infections. J Infect Dis. 2015;212(8):1237–1240.
   PubMed Web of Science ®Google Scholar
• Lee N, Lui GC, Wong KT, et al. High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin Infect Dis. 2013;57(8):1069–1077.
   PubMed Web of Science ®Google Scholar
• Lee N, Smith S, Zelyas N, et al. Burden of noninfluenza respiratory viral infections in adults admitted to hospital: analysis of a multiyear Canadian surveillance cohort from 2 centres. CMAJ. 2021;193(13):e439–e446.
   PubMed Web of Science ®Google Scholar
• Minney-Smith CA, Selvey LA, Levy A, et al. Post-pandemic influenza a/H1N1pdm09 is associated with more severe outcomes than a/H3N2 and other respiratory viruses in adult hospitalisations. Epidemiol Infect. 2019;147:e310.
   PubMed Web of Science ®Google Scholar
• Nam H, Ison MG. Respiratory syncytial disease in hospitalized adults: a retrospective cohort study. Open Forum Infect Dis. 2019;6(Supplement_2):S985–S986.
   Google Scholar
• Park SY, Kim T, Jang YR, et al. Factors predicting life-threatening infections with respiratory syncytial virus in adult patients. Infect Dis (Lond). 2017;49(5):333–340.
   PubMed Web of Science ®Google Scholar
• Schmidt H, Das A, Nam H, et al. Epidemiology and outcomes of hospitalized adults with respiratory syncytial virus: a 6-year retrospective study. Influenza Other Respir Viruses. 2019;13(4):331–338.
   PubMed Web of Science ®Google Scholar
• Sieling WD, Goldman CR, Oberhardt M, et al. Comparative incidence and burden of respiratory viruses associated with hospitalization in adults in New York city. Influenza Other Respir Viruses. 2021;15(5):670–677.
   PubMed Web of Science ®Google Scholar
• Smithgall M, Maykowski P, Zachariah P, et al. Epidemiology, clinical features, and resource utilization associated with respiratory syncytial virus in the community and hospital. Influenza Other Respir Viruses. 2020;14(3):247–256.
   PubMed Web of Science ®Google Scholar
• Vos LM, Oosterheert JJ, Hoepelman AIM, et al. External validation and update of a prognostic model to predict mortality in hospitalized adults with RSV: a retrospective dutch cohort study. J Med Virol. 2019;91(12):2117–2124.
   PubMed Web of Science ®Google Scholar
• Walsh EE, Saimon L, Branche AR, et al. Incidence and clinical outcomes of respiratory syncytial virus infection among hospitalized adults, 2017-2019. In: 5th ReSViNET Conference, Ghana; 2019.
   Google Scholar
• Wong SS, Yu JW, Wong KT, et al. Initial radiographic features as outcome predictor of adult respiratory syncytial virus respiratory tract infection. AJR Am J Roentgenol. 2014;203(2):280–286.
   PubMed Web of Science ®Google Scholar
• Wongsurakiat P, Sunhapanit S, Muangman N. Respiratory syncytial virus-associated acute respiratory illness in adult non-immunocompromised patients: outcomes, determinants of outcomes, and the effect of oral ribavirin treatment. Influenza Other Respir Viruses. 2022;16(4):767–779.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhao J, Zou X, et al. Severity of influenza virus and respiratory syncytial virus coinfections in hospitalized adult patients. J Clin Virol. 2020;133:104685.
   PubMed Web of Science ®Google Scholar
• Zhou JA, Schweinle JE, Lichenstein R, et al. Severe illnesses associated with outbreaks of respiratory syncytial virus and influenza in adults. Clin Infect Dis. 2020;70(5):773–779.
   PubMed Web of Science ®Google Scholar
• Belongia EA, King JP, Kieke BA, et al. Clinical features, severity, and incidence of RSV illness during 12 consecutive seasons in a community cohort of adults ≥ 60 years old. Open Forum Infect Dis. 2018;5(12):ofy316.
   PubMed Web of Science ®Google Scholar
• Hill-Ricciuti AC, Walsh EE, Greendyke WG, et al. Burden of healthcare-associated (HA) respiratory syncytial virus (RSV) in hospitalized adults. Open Forum Infect Dis. 2021;8(Supplement_1):S494–S494.
   Google Scholar
• Nolen LD, Seeman S, Desnoyers C, et al. Respiratory syncytial virus and influenza hospitalizations in Alaska native adults. J Clin Virol. 2020;127:104347.
   PubMed Web of Science ®Google Scholar
• Walker E, Ison MG. Respiratory viral infections among hospitalized adults: experience of a single tertiary healthcare hospital. Influenza Other Respir Viruses. 2014;8(3):282–292.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. People at high risk for severe RSV infection. 2020. https://www.cdc.gov/rsv/high-risk/index.html
   Google Scholar
• Walter JM, Corbridge TC, Singer BD. Invasive mechanical ventilation. South Med J. 2018;111(12):746–753.
   PubMed Web of Science ®Google Scholar
• Oxford Medical Information. Non-invasive ventilation (NIV). 2016. https://www.printfriendly.com/p/g/xN684V
   Google Scholar
• Kim L, Rha B, Abramson JS, et al. Identifying gaps in respiratory syncytial virus disease epidemiology in the United States prior to the introduction of vaccines. Clin Infect Dis. 2017;65(6):1020–1025.
   PubMed Web of Science ®Google Scholar
• Zhou H, Thompson WW, Viboud CG, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis. 2012;54(10):1427–1436.
   PubMed Web of Science ®Google Scholar
• Cheng X, Yang Y, Schwebel DC, et al. Population ageing and mortality during 1990-2017: a global decomposition analysis. PLoS Med. 2020;17(6):e1003138.
   PubMed Web of Science ®Google Scholar
• Shiels MS, Almeida JS, García-Closas M, et al. Impact of population growth and aging on estimates of excess U.S. deaths during the COVID-19 pandemic, march to august 2020. Ann Intern Med. 2021;174(4):437–443.
   PubMed Web of Science ®Google Scholar
• Herring WL, Zhang Y, Shinde V, et al. Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States. Vaccine. 2022;40(3):483–493.
   PubMed Web of Science ®Google Scholar
• Zeevat F, Luttjeboer J, Paulissen JHJ, et al. Exploratory analysis of the economically justifiable price of a hypothetical RSV vaccine for older adults in The Netherlands and the United Kingdom. J Infect Dis. 2022;226(Suppl 1):S102–S109.
   PubMed Web of Science ®Google Scholar
• Rozenbaum MH, Judy J, Tran D, et al. Low levels of RSV testing among adults hospitalized for lower respiratory tract infection in the United States. Infect Dis Ther. 2023;12(2):677–685.
   PubMed Web of Science ®Google Scholar
• Lee N, Walsh EE, Sander I, et al. Delayed diagnosis of respiratory syncytial virus infections in hospitalized adults: individual patient data, record review analysis and physician survey in the United States. J Infect Dis. 2019;220(6):969–979.
   PubMed Web of Science ®Google Scholar